Embecta (US:EMBC) Seeking Alpha·2026-01-14 23:45Company Overview - Embecta is a leader in diabetes injection supplies, recognized as the 1 producer of injection supplies globally [4] - The company has a stable and profitable business model with a significant global presence, serving approximately 30 million users annually [4] - Embecta produces 8 billion units of injection supplies annually from three manufacturing facilities, distributing these products to over 100 countries [4] Business Resilience and Cash Flow - The company emphasizes the durability and resilience of its business foundation, highlighting strong cash flow generation capabilities [3] Strategic Initiatives - An update on strategic initiatives that began last year will be provided, focusing on the company's future direction and growth strategies [3]